At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03692 HANSOH PHARMA
Trading 09-21 14:30:50
35.720
+1.420
+4.14%
High35.780
Low34.020
Vol7.68M
Open34.020
D1 Closing34.300
Amplitude5.13%
Mkt Cap216.61B
Tradable Cap216.61B
Total Shares6.06B
T/O271.87M
T/O Rate0.13%
Tradable Shares6.06B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Hansoh Rises on Positive Clinical Trial Results for Plaque Psoriasis Drug
Movement Alert｜HANSOH PHARMA Rises 3.12% in Regular Trading, B7-H3 ADC Phase III Data Reveals Record-Breaking Survival Benefit in Small Cell Lung Cancer
Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.